2 completed, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow Neoplasms, Endometrial: new trials by email Literature Review of Neoplasms, Endometrial trials Research Report on Neoplasms, Endometrial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC) Dostarlimab, Carboplatin, Paclitaxel - Neoplasms, Endometrial | Phase 2 | Recruiting | GlaxoSmithKline | 30 | 2025-11-27 | 2025-12-22 |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer pemetrexed - Neoplasms, Neoplasms by Site | Phase 2 | Completed | Eli Lilly and Company | 27 | 2006-09-01 | 2009-11-20 |
| Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer topotecan - Neoplasms, Endometrial, Endometrial Cancer | Phase 2 | Completed | GlaxoSmithKline | 70 | 2005-10-01 | 2012-07-11 |
Endometrial Neoplasms (3) · Genital Neoplasms, Female (1) · Neoplasms (1) · Neoplasms by Site (1) · Urogenital Neoplasms (1) · Uterine Neoplasms (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Urogenital Diseases (3) · Uterine Diseases (3) · Genital Neoplasms, Female (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Neoplasms (2) · Uterine Neoplasms (2) · Male Urogenital Diseases (1)
Carboplatin (1) · Paclitaxel (1) · Pemetrexed (1) · Topotecan (1) · dostarlimab (1)
GlaxoSmithKline (2) · Eli Lilly and Company (1)
United States (2) · Canada (1) · China (1) · Hungary (1)
David Miller, MD (1)